In Vivo

Combined in-vivo and in-vitro capabilities for faster efficacy assessment

23-Dec-2019 By Vassia Barba

Amylgen and Neuron-Experts partner to create a comprehensive offering of in-vivo and in-vitro efficacy evaluation for compounds in neurodegenerative diseases.

Real-time imaging platform tracks labeled cells in animal models

30-Sep-2019 By Vassia Barba

In Vivo Research Services has developed a 3D visualization technology that provides direct imaging data in real-time, aiming to reduce drug development time and costs.

Charles River to open flexible vivarium space in San Francisco

11-Jul-2019 By Melissa Fassbender

The new lab will provide customers with 'low cost, turnkey' vivarium space in addition to various in vivo support services.

Schrödinger enters three year partnership for TB drug discovery

18-Dec-2018 By Maggie Lynch

The three-year partnership between Schrödinger and TB Alliance will work toward identifying bacterial inhibitors for innovative TB therapies.

3D printed brain helps characterize 11 lead compounds, neuropathological research

12-Nov-2018 By Maggie Lynch

Celprogen’s 3D printed brain organoids are being used for neurological disease stage research and compound characterization.

KMT Hepatech expands humanized liver model services

04-Jan-2018 By Melissa Fassbender

KMT Hepatech is expanding its services with the PXB-Mouse – a humanized liver chimeric mouse model for drug discovery and development – following a strategic investment from PhoenixBio late last year.

Charles River expands CRISPR/Cas9 service offering

11-Dec-2017 By Melissa Fassbender

It is an “exciting time in drug discovery,” says Charles River CSO as the company expands its CRISPR/Cas9 service offering with a license from ERS Genomics.

AMRI adds in vitro bioequivalence testing at analytical services division

02-Nov-2017 By Melissa Fassbender

AMRI’s SSCI has announced the availability of in vitro bioequivalence testing services, as more products entering the market require laboratory-based testing.

EAG Labs now offering dermal absorption studies

19-Jan-2017 By Melissa Fassbender

EAG Laboratories has added dermal absorption studies to its GLP-compliant testing services suite, as part of the company’s plan to continue expanding its capabilities.

CRISPR/Cas9 transforming research, says Charles River CSO

06-Dec-2016 By Melissa Fassbender

Charles River Laboratories has announced an "end-to-end" service offering of CRISPR/Cas9 genome engineering technology, including custom in vivo and in vitro genome editing.

Bridging the 'cultural gap in drug development' with Silicon-Valley technology

02-Jun-2016 By Melissa Fassbender

Sensors, computer vision, machine learning, and cloud computing are enabling preclinical researchers to conduct higher quality studies in a shorter period of time. 

Cyprotex: Predictive toxicology tech will help pharma cut animal study spending

23-Nov-2015 By Gareth Macdonald

Cyprotex has expanded its toxicology offering with a new in silico technology it claims will reduce preclinical costs and cut the number of animal studies required.

Crown expands Precos site to build caucasian cancer expertise

12-Jan-2015 By Gareth Macdonald

Crown Biosciences has announced plans to double capacity at a site operated by its Precos division.

breaking news - update 2

CRL to buy Argenta and Biofocus from Galapagos for €134m

13-Mar-2014 By Gareth Macdonald

Preclinical CRO Charles River Labs has announced plans to buy discovery services firms Argenta and BioFocus from Galapagos NV.

Agilux doubles animal housing capacity

09-Dec-2013

Preclinical CRO Agilux has increased capacity at its research facility in Massachusetts, US, citing customer desire for faster in vivo studies as the driver for the investment.